NO304890B1 - Farmas°ytiske forbindelser og farmas°ytiske preparater - Google Patents

Farmas°ytiske forbindelser og farmas°ytiske preparater

Info

Publication number
NO304890B1
NO304890B1 NO934145A NO934145A NO304890B1 NO 304890 B1 NO304890 B1 NO 304890B1 NO 934145 A NO934145 A NO 934145A NO 934145 A NO934145 A NO 934145A NO 304890 B1 NO304890 B1 NO 304890B1
Authority
NO
Norway
Prior art keywords
pharmaceutical
compounds
preparations
pharmaceutical preparations
pharmaceutical compounds
Prior art date
Application number
NO934145A
Other languages
English (en)
Other versions
NO934145D0 (no
NO934145L (no
Inventor
Colin Peter Dell
Andrew Caerwyn Williams
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224169A external-priority patent/GB9224169D0/en
Priority claimed from GB939302367A external-priority patent/GB9302367D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of NO934145D0 publication Critical patent/NO934145D0/no
Publication of NO934145L publication Critical patent/NO934145L/no
Publication of NO304890B1 publication Critical patent/NO304890B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO934145A 1992-11-18 1993-11-16 Farmas°ytiske forbindelser og farmas°ytiske preparater NO304890B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224169A GB9224169D0 (en) 1992-11-18 1992-11-18 Pharmaceutical compounds
GB939302367A GB9302367D0 (en) 1993-02-06 1993-02-06 Pharmaceutical compounds

Publications (3)

Publication Number Publication Date
NO934145D0 NO934145D0 (no) 1993-11-16
NO934145L NO934145L (no) 1994-05-19
NO304890B1 true NO304890B1 (no) 1999-03-01

Family

ID=26301995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934145A NO304890B1 (no) 1992-11-18 1993-11-16 Farmas°ytiske forbindelser og farmas°ytiske preparater

Country Status (16)

Country Link
US (1) US5434160A (no)
EP (2) EP1004584A3 (no)
JP (1) JPH06199862A (no)
KR (1) KR940011465A (no)
CN (1) CN1040982C (no)
AU (1) AU668602B2 (no)
CA (1) CA2103203A1 (no)
CO (1) CO4130335A1 (no)
CZ (1) CZ243493A3 (no)
FI (1) FI103727B (no)
HU (1) HU9303261D0 (no)
IL (1) IL107627A (no)
NO (1) NO304890B1 (no)
NZ (1) NZ250195A (no)
PL (1) PL301059A1 (no)
TW (1) TW289755B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60008574T2 (de) 1999-11-05 2009-10-01 Cytovia, Inc., San Diego Substituierte 4H-Chromene und Analoga als Caspase-Aktivatoren und Apoptose-Induktoren und deren Verwendung
US6858607B1 (en) 2001-05-16 2005-02-22 Cytovia, Inc. 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1392283A4 (en) 2001-05-16 2004-10-20 Cytovia Inc COUMARINS AND SUBSTITUTED QUINOLINES USED AS CASPASE ACTIVATORS
WO2002092594A1 (en) 2001-05-16 2002-11-21 Cytovia, Inc. Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
AU2003230411A1 (en) * 2002-05-16 2003-12-02 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1513515A2 (en) 2002-05-16 2005-03-16 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
KR20070100878A (ko) 2004-09-09 2007-10-12 하워드 플로리 인스티튜트 오브 익스페러멘틀 피지알러지 앤드 메디신 효소 억제제 및 그 용도
US7843312B2 (en) * 2006-12-12 2010-11-30 Honeywell International Inc. Wireless control of security system with key-operated key fob
WO2009065169A1 (en) 2007-11-19 2009-05-28 Howard Florey Institute Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
CN103328463B (zh) 2010-11-12 2018-04-03 德国癌症研究中心 作为Wnt通路拮抗剂的色烯衍生物及其类似物
WO2023099589A1 (en) * 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases
CN115028643B (zh) * 2022-06-10 2024-03-22 中国药科大学 吡喃并喹啉衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
JPS61502124A (ja) * 1984-05-09 1986-09-25 ジ　オ−ストラリアン　ナシヨナル　ユニヴア−シテイ− 免疫応答の調節方法
JP2631710B2 (ja) * 1988-08-16 1997-07-16 日本ヘキスト・マリオン・ルセル株式会社 ピラノ〔ｆ〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物
US4931221A (en) * 1988-12-30 1990-06-05 Ppg Industries, Inc. Photochromic spiropyran compounds
US5284868A (en) * 1991-10-09 1994-02-08 Eli Lilly And Company Pharmaceutical compounds
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
US5434160A (en) 1995-07-18
FI103727B1 (fi) 1999-08-31
FI935065A0 (fi) 1993-11-16
IL107627A0 (en) 1994-02-27
KR940011465A (ko) 1994-06-21
HU9303261D0 (en) 1994-03-28
EP1004584A3 (en) 2000-07-05
CA2103203A1 (en) 1994-05-19
NO934145D0 (no) 1993-11-16
FI935065A (fi) 1994-05-19
PL301059A1 (en) 1994-05-30
CN1040982C (zh) 1998-12-02
EP0599514A2 (en) 1994-06-01
EP0599514A3 (en) 1994-07-06
CN1092072A (zh) 1994-09-14
CZ243493A3 (en) 1994-06-15
FI103727B (fi) 1999-08-31
NZ250195A (en) 1995-12-21
TW289755B (no) 1996-11-01
CO4130335A1 (es) 1995-02-13
AU668602B2 (en) 1996-05-09
IL107627A (en) 1997-04-15
EP1004584A2 (en) 2000-05-31
AU5067193A (en) 1994-06-02
JPH06199862A (ja) 1994-07-19
NO934145L (no) 1994-05-19

Similar Documents

Publication Publication Date Title
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
BR1100824A (pt) Composto e composição farmacêutica
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
BR1100329A (pt) Composto e formulação farmacêutica
NO305316B1 (no) Nye substituerte 1H-imidazoler og farmas°ytiske preparater inneholdende disse
DK108388A (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
NO930677L (no) Farmasoeytiske forbindelser
NO931831D0 (no) Farmasoeytiske blandinger
DK130389D0 (da) Catecholderivater og farmaceutiske praeparater omfatende samme
NO934372D0 (no) Nye forbindelser og farmas!ytisk preparat derav
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
NO931008D0 (no) Farmasoeytiske forbindelser
DK78888A (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
NO951350D0 (no) Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
DK40292A (da) Dibenzofurancarboxamider og farmaceutiske praeparater indeholdende disse
NO922812D0 (no) Naftyridin- og kinolizinderivater og farmasoeytiske preparater inneholdende disse
DK151785D0 (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
NO920039L (no) Farmasoeytiske preparater
NO941426D0 (no) Antisporiatiske farmasöytiske preparater og fremgangsmåte for fremstilling av slike

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2001